Healthcare · Drug Manufacturers - Specialty & Generic · $6.0B Mid Cap
58
Suggested Investment Score
Top 33.6% of 1,152 eligible
Risk
66
Long-Term
33
Fundamentals
99
Ownership
100
Valuation
61
Capital Returns
5
- Strengthening Fundamentals
- Broad Ownership Support